Axactor (ACR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Gross revenue nearly doubled year-over-year in Q4 2024 to EUR 161 million, mainly due to a Spanish portfolio sale; adjusted for this, revenue declined 4%.
Cash EBITDA rose to EUR 130 million from EUR 55 million, but excluding the portfolio sale, it declined 6%.
A significant negative revaluation of EUR 104 million was recorded, mainly impacting Sweden and Germany, leading to a book value decline of 14% quarter-over-quarter.
Return on equity (ROE) for 2024 was -19% due to the revaluation; excluding it, ROE was 6%.
The company maintains a solid balance sheet with a 26% equity ratio and over EUR 100 million in liquidity.
Financial highlights
Gross revenue for Q4 2024 was EUR 161 million, up from EUR 85 million in Q4 2023; excluding portfolio sales, revenue was EUR 82 million, down 4%.
NPL segment total revenue was EUR -59 million in Q4, mainly due to EUR 104 million in net negative revaluation; collection performance at 94%.
3PC segment revenue grew 5% to EUR 16 million; up 10% excluding closed operations in Sweden and Finland.
Operating expenses for 2024 decreased by 5%, with OPEX as a percentage of gross revenue dropping from 36% to 29%.
ERC (Estimated Remaining Collection) declined 11% due to portfolio sale and revaluation.
Outlook and guidance
Higher collection performance is expected after the Q4 revaluation.
OPEX is targeted to remain flat, with continued cost control despite inflation.
Cost of funding is expected to decrease due to lower IBOR rates and bond buybacks.
Investment in 2025 is expected at the lower end of the EUR 100-200 million target range.
3PC business is expected to continue solid growth at healthy margins, especially in Norway and Italy.
Latest events from Axactor
- Strong Q4 growth in NPL and 3PC, improved margins, and focus on deleveraging for 2026.ACR
Q4 202512 Feb 2026 - Cash EBITDA up 3% to EUR 61.1M as cost control offsets 2% revenue decline.ACR
Q2 20241 Feb 2026 - Gross revenue up 2% year-over-year, but net profit and ROE to shareholders fell to 0%.ACR
Q3 202417 Jan 2026 - Record 12% ROE, 50% EBITDA margin, and 28% 3PC growth highlight strong Q1 results.ACR
Q1 202525 Nov 2025 - Refinancing, strong collections, and 3PC growth support a positive outlook.ACR
Q2 202523 Nov 2025 - Double-digit growth, 53% EBITDA margin, and strong 3PC/NPL performance drive positive outlook.ACR
Q3 202530 Oct 2025 - Spanish portfolio sales and bond buybacks boost Axactor's financial flexibility.ACR
Investor Presentation6 Jun 2025